Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC1 | Q13547 | 17/20 | 0.52 |
| ▸ | HDAC2 | Q92769 | 16/20 | 0.52 |
| ▸ | HDAC4 | P56524 | 16/20 | 0.52 |
| ▸ | HDAC7 | Q8WUI4 | 16/20 | 0.52 |
| ▸ | HDAC11 | Q96DB2 | 16/20 | 0.52 |
| ▸ | HDAC8 | Q9BY41 | 16/20 | 0.52 |
| ▸ | HDAC6 | Q9UBN7 | 16/20 | 0.52 |
| ▸ | HDAC9 | Q9UKV0 | 16/20 | 0.52 |
| ▸ | HDAC5 | Q9UQL6 | 16/20 | 0.52 |
| ▸ | HDAC3 | O15379 | 15/20 | 0.52 |
| ▸ | HDAC10 | Q969S8 | 15/20 | 0.52 |
| ▸ | PPARA | Q07869 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | BRD4 | O60885 | 1/20 | 0.41 |
| ▸ | NCOR1 | O75376 | 1/20 | 0.41 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.41 |
| ▸ | EGFR | P00533 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | LTA4H | P09960 | 1/20 | 0.41 |
| ▸ | NR0B1 | P51843 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL944263 | 0.98 | HDAC1 (0.51) | HDAC1HDAC2HDAC4HDAC7HDAC11 | |
| SCHEMBL943176 | 0.93 | HDAC3 (0.46) | HDAC1HDAC2HDAC4HDAC7HDAC11 | |
| SCHEMBL941520 | 0.86 | ALDH1A1 (0.46) | HDAC1HDAC2HDAC4HDAC7HDAC11 | |
| Carbamic Acid SCHEMBL28182397 | 0.83 | LMNA (0.50) | HDAC1HDAC2HDAC4HDAC7HDAC11 | |
| SCHEMBL2911694 | 0.82 | HDAC1 (0.42) | HDAC1HDAC2HDAC4HDAC7HDAC11 | |
| SCHEMBL3366323 | 0.82 | HDAC1 (0.42) | HDAC1HDAC2HDAC4HDAC7HDAC11 | |
| SCHEMBL2803168 | 0.78 | LTA4H (0.46) | NR1I2CYP3A4LTA4HKCNH2 | |
| SCHEMBL11672538 | 0.78 | LTA4H (0.46) | NR1I2CYP3A4LTA4HKCNH2 | |
| SCHEMBL18049455 | 0.78 | LTA4H (0.46) | NR1I2CYP3A4LTA4HKCNH2 | |
| SCHEMBL3523840 | 0.78 | LTA4H (0.46) | NR1I2CYP3A4LTA4HKCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8372985-B2 | Process of making α-aminooxyketone/α-aminooxyaldehyde and α-hydroxyketone/α-hydroxyaldehyde compounds and a process of making reaction products from cyclic α, β-unsaturated ketone substrates and nitroso substrates | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2013-02-12 | — | — | US | disclosed |
| US-20120302792-A1 | PROCESS OF MAKING ALPHA-AMINOOXYKETONE/ALPHA-AMINOOXYALDEHYDE AND ALPHA-HYDROXYKETONE/ALPHA-HYDROXYALDEHYDE COMPOUNDS AND A PROCESS MAKING REACTION PRODUCTS FROM CYCLIC ALPHA, BETA-UNSATURATED KETONE SUBSTRATES AND NITROSO SUBSTRATES | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2012-11-29 | — | — | US | disclosed |
| US-8252941-B2 | Process of making alpha-aminooxyketone/alpha-aminooxyaldehyde and alpha-hydroxyketone/alpha-hydroxyaldehyde compounds and a process making reaction products from cyclic alpha, beta-unsaturated ketone substrates and nitroso substrates | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2012-08-28 | — | — | US | disclosed |
| US-7872123-B2 | Process of making α-aminooxyketone/α-aminooxyaldehyde and α-hydroxyketone/α-hydroxyaldehyde compounds and a process making reaction products from cyclic α,β-unsaturated ketone substrates and nitroso substrates | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2011-01-18 | — | — | US | disclosed |
| US-20100099915-A1 | PROCESS OF MAKING ALPHA-AMINOOXYKETONE/ALPHA-AMINOOXYALDEHYDE AND ALPHA-HYDROXYKETONE/ALPHA-HYDROXYALDEHYDE COMPOUNDS AND A PROCESS MAKING REACTION PRODUCTS FROM CYCLIC ALPHA, BETA-UNSATURATED KETONE SUBSTRATES AND NITROSO SUBSTRATES | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2010-04-22 | — | — | US | disclosed |
| US-20070037973-A1 | reacting a cyclic alpha , beta -unsaturated ketone compound with a nitroso compound in the presence of a proline-based catalyst to provide 7-Phenyl-6-oxa-7-aza-bicyclo[3.2.2]nonan-9-one or derivatives; catalytic asymmetric O-nitroso Aldol/Michael reaction | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2007-02-15 | — | — | US | disclosed |
| EP-1742905-A2 | PROCESS OF MAKING ALFA-AMINOOXYKETONE/ ALFA-AMINOOXYALDEHYDE AND ALFA-HYDROXYKETONE/ ALFA-HYDROXYALDEHYDE COMPOUNDS AND A PROCESS OF MAKING REACTION PRODUCTS FROM CYCLIC ALFA, BETA-UNSATURATED KETONE SUBSTRATES AND NITROSO SUBSTRATES | Japan Science and Technology Agency (JP) | 2007-01-17 | — | — | EP | disclosed |
| WO-2005090294-A2 | PROCESS OF MAKING α-AMINOOXYKETONE/α-AMINOOXYALDEHYDE AND α-HYDROXYKETONE/α-HYDROXYALDEHYDE COMPOUNDS AND A PROCESS OF MAKING REACTION PRODUCTS FROM CYCLIC α,ß-UNSATURATED KETONE SUBSTRATES AND NITROSO SUBSTRATES | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2005-09-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070037973-A1 | reacting a cyclic alpha , beta -unsaturated ketone compound with a nitroso compound in the presence of a proline-based catalyst to provide 7-Phenyl-6-oxa-7-aza-bicyclo[3.2.2]nonan-9-one or derivatives; catalytic asymmetric O-nitroso Aldol/Michael reaction | XDH, PDXK, AOX1 | HDAC1 1316/4885HDAC2 1404/4885HDAC4 1095/4885 |
| US-20100099915-A1 | PROCESS OF MAKING ALPHA-AMINOOXYKETONE/ALPHA-AMINOOXYALDEHYDE AND ALPHA-HYDROXYKETONE/ALPHA-HYDROXYALDEHYDE COMPOUNDS AND A PROCESS MAKING REACTION PRODUCTS FROM CYCLIC ALPHA, BETA-UNSATURATED KETONE SUBSTRATES AND NITROSO SUBSTRATES | XDH, QSOX1, KMO | HDAC1 2785/4885HDAC2 2615/4885HDAC4 1581/4885 |
| US-20120302792-A1 | PROCESS OF MAKING ALPHA-AMINOOXYKETONE/ALPHA-AMINOOXYALDEHYDE AND ALPHA-HYDROXYKETONE/ALPHA-HYDROXYALDEHYDE COMPOUNDS AND A PROCESS MAKING REACTION PRODUCTS FROM CYCLIC ALPHA, BETA-UNSATURATED KETONE SUBSTRATES AND NITROSO SUBSTRATES | XDH, AOX1, QSOX1 | HDAC1 2687/4885HDAC2 2821/4885HDAC4 1363/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.